Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Eye (London, England)
|
May 20, 2026
Pharmacological principles of intravitreal drug therapy and their implications for clinical practice: a primer for the ophthalmologist
Samia Ezzine, Richard Gale, Clare Bailey, et al.
Clinical Pharmacokinetics
|
November 13, 2021
Finerenone Dose-Exposure-Response for the Primary Kidney Outcome in FIDELIO-DKD Phase III: Population Pharmacokinetic and Time-to-Event Analysis
Paul van den Berg, Martijn Ruppert, Emir Mesic, et al.
Journal of Clinical Pharmacology
|
June 29, 2021
Predictive Performance of Physiology-Based Pharmacokinetic Dose Estimates for Pediatric Trials: Evaluation With 10 Bayer Small-Molecule Compounds in Children
Ibrahim Ince, André Dallmann, Sebastian Frechen, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 1, 2026
Integrated Population Pharmacokinetic Analysis of Intravitreal Aflibercept Drug Products
Sébastien Bihorel, Joannellyn Chiu, Jason Chittenden, et al.
Diabetes, Obesity & Metabolism
|
December 1, 2023
Pharmacokinetics and pharmacodynamics of finerenone in patients with chronic kidney disease and type 2 diabetes: Insights based on FIGARO-DKD and FIDELIO-DKD
Thomas Eissing, Sebastiaan Camiel Goulooze, Paul van den Berg, et al.
Eye (London, England)
|
January 10, 2024
Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study
Andreas Stahl, Noriyuki Azuma, Wei-Chi Wu, et al.
Frontiers in Physiology
|
April 13, 2011
A computational systems biology software platform for multiscale modeling and simulation: integrating whole-body physiology, disease biology, and molecular reaction networks
Thomas Eissing, Lars Kuepfer, Corina Becker, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
February 8, 2023
Evaluating Kidney Function Decline in Children with Chronic Kidney Disease Using a Multi-Institutional Electronic Health Record Database
Caroline A Gluck, Christopher B Forrest, Amy Goodwin Davies, et al.
Lancet (London, England)
|
June 5, 2026
Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY)
Brendon L Neuen, Hiddo J L Heerspink, Vlado Perkovic, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Eye (London, England)
|
May 20, 2026
Pharmacological principles of intravitreal drug therapy and their implications for clinical practice: a primer for the ophthalmologist
Samia Ezzine, Richard Gale, Clare Bailey, et al.
Clinical Pharmacokinetics
|
November 13, 2021
Finerenone Dose-Exposure-Response for the Primary Kidney Outcome in FIDELIO-DKD Phase III: Population Pharmacokinetic and Time-to-Event Analysis
Paul van den Berg, Martijn Ruppert, Emir Mesic, et al.
Journal of Clinical Pharmacology
|
June 29, 2021
Predictive Performance of Physiology-Based Pharmacokinetic Dose Estimates for Pediatric Trials: Evaluation With 10 Bayer Small-Molecule Compounds in Children
Ibrahim Ince, André Dallmann, Sebastian Frechen, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 1, 2026
Integrated Population Pharmacokinetic Analysis of Intravitreal Aflibercept Drug Products
Sébastien Bihorel, Joannellyn Chiu, Jason Chittenden, et al.
Diabetes, Obesity & Metabolism
|
December 1, 2023
Pharmacokinetics and pharmacodynamics of finerenone in patients with chronic kidney disease and type 2 diabetes: Insights based on FIGARO-DKD and FIDELIO-DKD
Thomas Eissing, Sebastiaan Camiel Goulooze, Paul van den Berg, et al.
Eye (London, England)
|
January 10, 2024
Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study
Andreas Stahl, Noriyuki Azuma, Wei-Chi Wu, et al.
Frontiers in Physiology
|
April 13, 2011
A computational systems biology software platform for multiscale modeling and simulation: integrating whole-body physiology, disease biology, and molecular reaction networks
Thomas Eissing, Lars Kuepfer, Corina Becker, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
February 8, 2023
Evaluating Kidney Function Decline in Children with Chronic Kidney Disease Using a Multi-Institutional Electronic Health Record Database
Caroline A Gluck, Christopher B Forrest, Amy Goodwin Davies, et al.
Lancet (London, England)
|
June 5, 2026
Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY)
Brendon L Neuen, Hiddo J L Heerspink, Vlado Perkovic, et al.
Page
of 5